As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Zepbound works by modulating appetite and glycemic signals, slowing gastric emptying, and improving satiety signals to the brain
Built on trust
These studies reported HbA1c reductions ranging from 1.2 to 1.8 percentage points over 10 to 13 months of treatment
Latent iron deficiency alters -aminobutyric acid and glutamate metabolism in rat brain
With the allure of easy weight loss in a sport thats weight-sensitive when the road starts to incline, and that places a high value on the stick-thin physique of many of its global superstars, its not surprising that Ozempic, Wegovy, Mounjaro, and related drugs would turn up in our sport
On the one hand, insurers recognize the potential for GLP-1 drugs to reduce costly chronic conditions, but on the other, are wary of the sheer scale and cost of widespread adoption